Evidence map›Paper›PMID 23633618›Full record

ArticleThe Journal of pharmacology and experimental therapeutics2013

A structural snapshot of CYP2B4 in complex with paroxetine provides insights into ligand binding and clusters of conformational states.

Manish B Shah, Irina Kufareva, Jaime Pascual, Qinghai Zhang, C David Stout, James R Halpert

Abstract read
In one paragraph

Article in The Journal of pharmacology and experimental therapeutics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Paroxetine-Overview of the Molecular Mechanisms of Action.International journal of molecular sciences · 2021
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Manish B ShahSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, 9500 Gilman Drive, Mail Code 0703, La Jolla, CA 92093-0703, USA. m7shah@ucsd.edu
Irina Kufareva
Jaime Pascual
Qinghai Zhang
C David Stout
James R Halpert

Funding

STRUCTURAL BASIS OF SELECTIVE P-450 INACTIVATIONR01ES003619 · NIEHS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI HALPERT, JAMES R · 1985 to 2016
$6.2M
Macromolecular DockingR01GM071872 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ABAGYAN, RUBEN · 2004 to 2017
$4.2M
Mediating Membrane Protein Crystal Contacts by Stabilization ReagentsR01GM098538 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI ZHANG, QINGHAI · 2011 to 2015
$1.8M
NIEHS NIH HHS ES003619NIEHS NIH HHS R01 ES003619NIGMS NIH HHS GM071872NIGMS NIH HHS GM098538NIGMS NIH HHS R01 GM071872NIGMS NIH HHS R01 GM098538
6 · The paper itself

Abstract

An X-ray crystal structure of CYP2B4 in complex with the drug paroxetine [(3S,4R)-3-[(2H-1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine] was solved at 2.14 Å resolution. The structure revealed a conformation intermediate to that of the recently solved complex with amlodipine and that of the more compact complex with 4-(4-chlorophenyl)imidazole in terms of the placement of the F-G cassette. Moreover, comparison of the new structure with 15 previously solved structures of CYP2B4 revealed some new insights into the determinants of active-site size and shape. The 2B4-paroxetine structure is nearly superimposable on a previously solved closed structure in a ligand-free state. Despite the overall conformational similarity among multiple closed structures, the active-site cavity volume of the paroxetine complex is enlarged. Further analysis of the accessible space and binding pocket near the heme reveals a new subchamber that resulted from the movement of secondary structural elements and rearrangements of active-site side chains. Overall, the results from the comparison of all 16 structures of CYP2B4 demonstrate a cluster of protein conformations that were observed in the presence or absence of various ligands.

Indexed as

Models, MolecularAmino Acid SubstitutionAnimalsAntidepressive Agents, Second-GenerationAryl Hydrocarbon HydroxylasesCatalytic DomainCrystallography, X-RayCytochrome P-450 Enzyme InhibitorsCytochrome P-450 Enzyme SystemCytochrome P450 Family 2Databases, ProteinEnzyme InhibitorsLigandsMolecular ConformationMutant ProteinsParoxetineAntidepressive Agents, Second-GenerationAryl Hydrocarbon Hydroxylasescytochrome P-450 CYP2B4 (rabbit)cytochrome P-450 CYP2B4, ratCytochrome P-450 Enzyme InhibitorsCytochrome P-450 Enzyme SystemCytochrome P450 Family 2Enzyme InhibitorsLigandsMutant ProteinsParoxetinePeptide FragmentsRecombinant ProteinsSelective Serotonin Reuptake Inhibitors

Identifiers

PMID23633618
PMCPMC3684837

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.